Acuren Corp
NYSE:TIC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (19.5), the stock would be worth $16.66 (124% upside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 8.7 | $7.45 |
0%
|
| 3-Year Average | 19.5 | $16.66 |
+124%
|
| 5-Year Average | 19.5 | $16.66 |
+124%
|
| Industry Average | 15.5 | $13.19 |
+77%
|
| Country Average | 13.3 | $11.39 |
+53%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Acuren Corp
NYSE:TIC
|
1.6B USD | 8.7 | -8.8 | |
| UK |
|
Relx PLC
LSE:REL
|
49B GBP | 17.3 | 23.7 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 29.6 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
55B CAD | 14.7 | 26.1 | |
| IE |
|
Experian PLC
LSE:EXPN
|
25.1B GBP | 15.7 | 24.6 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
24.6B USD | 17.1 | 27.1 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.5B CHF | 13.4 | 24.6 | |
| US |
|
Equifax Inc
NYSE:EFX
|
20.6B USD | 12.6 | 29.4 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
18.5B USD | 10.5 | 12.7 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
18.1B USD | 0 | 0 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
15B EUR | 9 | 11.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 13.3 |
| 70th Percentile | 20.1 |
| Max | 3 188 432.5 |
Other Multiples
Acuren Corp
Glance View
Acuren Corp. engages in providing nondestructive testing, inspection, engineering and lab testing services. The company is headquartered in Tomball, Texas. The company went IPO on 2023-10-12. The firm provide these essential and often compliance-mandated (often at customer locations) services in the industrial space and are focused on the recuring maintenance needs of its customers. The firm operates in the service category referred to as Testing, Inspection and Certification (TIC). These activities include Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection. NDT activities include inspection and evaluation of industrial equipment through various technology-enabled methods to ensure asset integrity, avoid costly accidents and comply with regulatory requirements without destroying the asset or component. The company operates from approximately 119 service centers and over 22 engineering and lab facilities. The company operates in the United States and Canada, and has limited operations located in the United Kingdom.
